Neuromodulation Devices and Associated Products 2023

Non-exclusive Framework Agreement (FAG) for the supply to the NHS Supply Chain customer base via the E-Direct Route. Product range to include, but not limited to stimulation of; Deep Brain, Spinal Cord, Sacral Nerve, Vagal Nerve, Dorsal Route ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Drug Delivery Pumps and Dorsal Ramus Medial Branch nerve that meet the requirements of users and patients. The FAG will provide access to Neuromodulation Devices/Consumables that are associated with Neuromodulation procedures.

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £187,484,968.00 for the initial term of FAG, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the FAG. The estimated value over the total FAG term (including any extension options) is £457,463,323.00